Veterinary Autoimmune Disease Therapeutics Global Market Report 2024

Description

Veterinary autoimmune disease therapeutics encompass treatments tailored to manage and alleviate animal autoimmune conditions. These therapies are geared towards modulating or suppressing the immune response to mitigate inflammation, halt further tissue damage, and enhance the overall well-being and quality of life of affected animals. Given the complexity of these conditions, veterinary autoimmune disease therapeutics necessitate a customized approach, taking into account the specific disease, its severity, and the individual needs of the animal.

The primary types of therapy within veterinary autoimmune disease therapeutics include corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, folic acid, hydroxychloroquine, and chloroquine. Corticosteroids, derived from steroid hormones produced in the adrenal cortex, are commonly utilized in medicine to diminish inflammation and suppress immune activity. They are administered to various animals, including companion and livestock animals, to address conditions such as disease-type hypothyroidism, pemphigus disease, canine lupus, autoimmune hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, among others. These therapeutic agents are typically dispensed through veterinary hospitals and clinics.

The veterinary autoimmune disease therapeutics research report is one of a series of new reports from The Business Research Company that provides veterinary autoimmune disease therapeutics market statistics, including the veterinary autoimmune disease therapeutics industry's global market size, regional shares, competitors with a veterinary autoimmune disease therapeutics market share, detailed veterinary autoimmune disease therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary autoimmune disease therapeutics industry. This veterinary autoimmune disease therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary autoimmune disease therapeutics market size has grown strongly in recent years. It will grow from $3.05 billion in 2023 to $3.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The increase in the historic period can be credited to progress in immunology, higher rates of pet ownership, enhanced diagnostic techniques, the emergence of new medication categories, and heightened awareness of pet well-being.

The veterinary autoimmune disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.20 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. In the projected period, growth can be ascribed to advancements in biotechnology, greater investments in veterinary healthcare, the escalating incidence of autoimmune disorders in animals, the creation of innovative treatments, and the expanding adoption of pet insurance. Prominent trends expected in the forecasted period encompass tailored medical approaches, utilization of biologics, incorporation of telemedicine, uptake of regenerative therapies, and a focus on holistic and integrated treatments, such as personalized medicine, biologics usage, telemedicine integration, regenerative therapy adoption, and emphasis on holistic and integrative remedies.

The increased funding for research in veterinary medicine is anticipated to drive the growth of the veterinary autoimmune disease therapeutics market in the coming years. Veterinary medicine, which focuses on preventing, diagnosing, and treating diseases, disorders, and injuries in animals, is receiving more funding due to various factors such as rising zoonotic diseases, the expanding pet industry, technological advancements in animal health, agricultural needs, and wildlife conservation efforts. This increased funding supports research on veterinary autoimmune diseases, including studies on disease mechanisms, diagnostic tools, and treatment options, thereby enhancing the ability to diagnose and manage these conditions effectively. For example, the National Institute of Food and Agriculture announced the Veterinary Service Grants Program in August 2024, investing $3.2 million in rural food animal veterinary medicine in the fiscal year 2022 across the United States. Hence, the heightened research funding in veterinary medicine is propelling the growth of the veterinary autoimmune disease therapeutics market.

Key players in the veterinary autoimmune disease therapeutics market are focusing on developing autoimmune disease research projects to advance treatment options and enhance animal health outcomes. These projects help in uncovering disease mechanisms, leading to the development of more effective and targeted treatments. For instance, the Royal Veterinary College launched the ImmunoRegistry in November 2021, a comprehensive research project aimed at improving the understanding and management of autoimmune diseases in dogs. This project involves an observational registry collecting real-time data on dogs diagnosed with autoimmune diseases over one year after diagnosis, aiming to gather detailed information about disease progression and treatment effectiveness in various dog breeds.

In February 2021, Merk & Co. Inc. acquired Pandion Therapeutics Inc., a biopharmaceutical company focusing on novel therapies for veterinary autoimmune diseases. With this acquisition, Merck aims to identify and develop candidates with unique and potentially fundamental traits, thereby strengthening its position in the veterinary autoimmune disease therapeutics market and contributing to advancements in treating autoimmune diseases in animals.

Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited

North America was the largest region in the veterinary autoimmune disease therapeutics market in 2023. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary autoimmune disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary autoimmune disease therapeutics market consists of revenues earned by entities by providing immunosuppressive medications, biologic therapies, supportive therapies and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary autoimmune disease therapeutics market also includes sales of prednisone, mycophenolate mofetil, and methotrexate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Autoimmune Disease Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary autoimmune disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary autoimmune disease therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary autoimmune disease therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Corticosteroids; Azathioprine; Cyclosporine; Mycophenolate; Leflunomide; Cyclophosphamide; Levothyroxine; Folic Acid; Hydroxychloroquine; Chloroquine
2) By Animal Type: Companion Animals; Livestock Animals; Other Animals
3) By Disease: Hypothyroidism; Pemphigus Disease; Canine Lupus; Auto-Immune Hemolytic Anemia; Bullous Pemphigoid; Discoid Lupus Erythematosus (DLE); Immune-Related Arthritis; Other Diseases
4) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics
Companies Mentioned: Pfizer Inc; Merck & Co Inc; AbbVie Inc.; Sanofi S.A.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18759

1. Executive Summary

2. Veterinary Autoimmune Disease Therapeutics Market Characteristics

3. Veterinary Autoimmune Disease Therapeutics Market Trends And Strategies

4. Veterinary Autoimmune Disease Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Veterinary Autoimmune Disease Therapeutics Market Size and Growth

5.1. Global Veterinary Autoimmune Disease Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Veterinary Autoimmune Disease Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Veterinary Autoimmune Disease Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Autoimmune Disease Therapeutics Market Segmentation

6.1. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Corticosteroids
Azathioprine
Cyclosporine
Mycophenolate
Leflunomide
Cyclophosphamide
Levothyroxine
Folic Acid
Hydroxychloroquine
Chloroquine
6.2. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Companion Animals
Livestock Animals
Other Animals
6.3. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hypothyroidism
Pemphigus Disease
Canine Lupus
Auto-Immune Hemolytic Anemia
Bullous Pemphigoid
Discoid Lupus Erythematosus (DLE)
Immune-Related Arthritis
Other Diseases
6.4. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Veterinary Hospitals
Veterinary Clinics

7. Veterinary Autoimmune Disease Therapeutics Market Regional And Country Analysis

7.1. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market

8.1. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Autoimmune Disease Therapeutics Market

9.1. China Veterinary Autoimmune Disease Therapeutics Market Overview
9.2. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Autoimmune Disease Therapeutics Market

10.1. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Autoimmune Disease Therapeutics Market

11.1. Japan Veterinary Autoimmune Disease Therapeutics Market Overview
11.2. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Autoimmune Disease Therapeutics Market

12.1. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Autoimmune Disease Therapeutics Market

13.1. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Autoimmune Disease Therapeutics Market

14.1. South Korea Veterinary Autoimmune Disease Therapeutics Market Overview
14.2. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Autoimmune Disease Therapeutics Market

15.1. Western Europe Veterinary Autoimmune Disease Therapeutics Market Overview
15.2. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Autoimmune Disease Therapeutics Market

16.1. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Autoimmune Disease Therapeutics Market

17.1. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Autoimmune Disease Therapeutics Market

18.1. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Autoimmune Disease Therapeutics Market

19.1. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Autoimmune Disease Therapeutics Market

20.1. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market

21.1. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market Overview
21.2. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Autoimmune Disease Therapeutics Market

22.1. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Autoimmune Disease Therapeutics Market

23.1. North America Veterinary Autoimmune Disease Therapeutics Market Overview
23.2. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Autoimmune Disease Therapeutics Market

24.1. USA Veterinary Autoimmune Disease Therapeutics Market Overview
24.2. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Autoimmune Disease Therapeutics Market

25.1. Canada Veterinary Autoimmune Disease Therapeutics Market Overview
25.2. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Autoimmune Disease Therapeutics Market

26.1. South America Veterinary Autoimmune Disease Therapeutics Market Overview
26.2. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Autoimmune Disease Therapeutics Market

27.1. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Autoimmune Disease Therapeutics Market

28.1. Middle East Veterinary Autoimmune Disease Therapeutics Market Overview
28.2. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Autoimmune Disease Therapeutics Market

29.1. Africa Veterinary Autoimmune Disease Therapeutics Market Overview
29.2. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape And Company Profiles

30.1. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape
30.2. Veterinary Autoimmune Disease Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co Inc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi S.A.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Veterinary Autoimmune Disease Therapeutics Market Other Major And Innovative Companies

31.1. GlaxoSmithKline
31.2. Takeda Pharmaceutical Company
31.3. Amgen Inc.
31.4. Teva Pharmaceuticals Industries Ltd.
31.5. Zoetis Inc
31.6. Boehringer Ingelheim International GmbH
31.7. Sumitomo Pharma Co. Ltd.
31.8. IDEXX Laboratories Inc.
31.9. Cipla Inc.
31.10. Mallinckrodt Pharmaceuticals
31.11. Virbac S.A
31.12. Dechra Pharmaceuticals plc
31.13. Neogen Corporation
31.14. Vetoquinol S.A.
31.15. Norbrook Laboratories Limited

32. Global Veterinary Autoimmune Disease Therapeutics Market Competitive Benchmarking

33. Global Veterinary Autoimmune Disease Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Autoimmune Disease Therapeutics Market

35. Veterinary Autoimmune Disease Therapeutics Market Future Outlook and Potential Analysis

35.1 Veterinary Autoimmune Disease Therapeutics Market In 2028 - Countries Offering Most New Opportunities
35.2 Veterinary Autoimmune Disease Therapeutics Market In 2028 - Segments Offering Most New Opportunities
35.3 Veterinary Autoimmune Disease Therapeutics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer